A pilot project, led by the City of Hamilton and involving McMaster University and AllerGen partner Anaphylaxis Canada, is being launched today (September 8, 2014) in Hamilton. The project will analyze the effects of stocking epinephrine auto-injectors at Jackson Square …
PRESIDENT Lianne Soller – McGill University Lianne is a Ph.D. candidate in Epidemiology at McGill University under the supervision of Dr. Ann Clarke. Her research, for which she has been awarded an FRQS Doctoral Award, focuses on the prevalence and …
In a new study published August 13, 2014, by The Journal of Maternal-Fetal & Neonatal Medicine, AllerGen trainee Ryan Persaud and a team of AllerGen researchers found that Canadian newborns are routinely exposed to antibiotics immediately before or after birth. …
Canadian newborns are routinely exposed to antibiotics Read More »
Allergy researchers at The University of British Columbia (UBC) have found that antibiotic use in early life alters gut bacteria and enhances future susceptibility to inflammatory lung disease. The study, led by AllerGen investigator Dr. Kelly McNagny, a professor in …
A new study by AllerGen researchers has shown that children treated with antibiotics in the first year of life are more than twice as likely to be overweight later in childhood compared to children who were unexposed. The study, published …
New study links antibiotic use to overweight in children Read More »
Read Dr. Meghan Azad’s informal report on her participation in the 64th Lindau Nobel Laureate Meeting in Lindau, Germany, available here. Dr. Azad thanks the Canadian Institutes of Health Research (CIHR) for nominating her for inclusion in the event and …
AllerGen trainee reports back from meeting with Nobel Laureates Read More »
Dr. Michael Brauer, an AllerGen investigator and a professor in the School of Population and Public Health at The University of British Columbia (UBC), is leading a new study that will provide an unparalleled worldwide analysis of the relationship between …
AllerGen researcher funded to lead worldwide study of air pollution and disease Read More »
Dr. Malcolm Sears, an AllerGen research leader and a professor of medicine at McMaster University, together with a team of CHILD researchers from across Canada, has received a five-year operating grant, valued at over $1 million, from the Canadian Institutes …
CHILD research team awarded five-year CIHR grant Read More »
AllerGen will partner in the Emerging Research Leaders Initiative (ERLI)—an establishment grant program for researchers at the transition stage from post-doctoral fellow to early career professional in the areas of cardiovascular, cerebrovascular, and/or respiratory health research. This multi-partnered initiative is …
An AllerGen investigator is among 90 Canadians named in Thomson Reuters’ new compilation of “The World’s Most Influential Scientific Minds: 2014.” Dr. Fiona Brinkman, a professor in the Department of Molecular Biology and Biochemistry at Simon Fraser University, was ranked …
AllerGen investigator chosen for 2014 “World’s Most Influential Scientific Minds” Read More »
AllerGen investigator Dr. Kelly McNagny (The University of British Columbia) is co-editor of a new edition of Mast Cells: Methods and Protocols, a volume in the Methods in Molecular Biology series published by Humana Press. The text is intended for …
Network members contribute to new volume on the study of mast cells Read More »
Researchers in AllerGen’s Clinical Investigator Collaborative (CIC) have shown that a new drug (quilizumab) successfully blocks the production of an immune system protein, reducing symptoms of allergic asthma. The study, led by Dr. Gail Gauvreau (McMaster University), was conducted by …
CIC investigators test new drug for allergic asthma Read More »